303 related articles for article (PubMed ID: 33285233)
1. Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in schizophrenia: Analyses in patients and in perinatal Δ9-tetrahydrocannabinol-exposed rats.
Di Bartolomeo M; Stark T; Maurel OM; Iannotti FA; Kuchar M; Ruda-Kucerova J; Piscitelli F; Laudani S; Pekarik V; Salomone S; Arosio B; Mechoulam R; Maccarrone M; Drago F; Wotjak CT; Di Marzo V; Vismara M; Dell'Osso B; D'Addario C; Micale V
Pharmacol Res; 2021 Feb; 164():105357. PubMed ID: 33285233
[TBL] [Abstract][Full Text] [Related]
2. The Effects of Peripubertal THC Exposure in Neurodevelopmental Rat Models of Psychopathology.
Di Bartolomeo M; Stark T; Di Martino S; Iannotti FA; Ruda-Kucerova J; Romano GL; Kuchar M; Laudani S; Palivec P; Piscitelli F; Wotjak CT; Bucolo C; Drago F; Di Marzo V; D'Addario C; Micale V
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835313
[TBL] [Abstract][Full Text] [Related]
3. Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia.
Stark T; Ruda-Kucerova J; Iannotti FA; D'Addario C; Di Marco R; Pekarik V; Drazanova E; Piscitelli F; Bari M; Babinska Z; Giurdanella G; Di Bartolomeo M; Salomone S; Sulcova A; Maccarrone M; Wotjak CT; Starcuk Z; Drago F; Mechoulam R; Di Marzo V; Micale V
Neuropharmacology; 2019 Mar; 146():212-221. PubMed ID: 30496751
[TBL] [Abstract][Full Text] [Related]
4. Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment.
Stark T; Di Bartolomeo M; Di Marco R; Drazanova E; Platania CBM; Iannotti FA; Ruda-Kucerova J; D'Addario C; Kratka L; Pekarik V; Piscitelli F; Babinska Z; Fedotova J; Giurdanella G; Salomone S; Sulcova A; Bucolo C; Wotjak CT; Starcuk Z; Drago F; Mechoulam R; Di Marzo V; Micale V
Biochem Pharmacol; 2020 Jul; 177():114004. PubMed ID: 32360362
[TBL] [Abstract][Full Text] [Related]
5. Immunodensity and mRNA expression of A2A adenosine, D2 dopamine, and CB1 cannabinoid receptors in postmortem frontal cortex of subjects with schizophrenia: effect of antipsychotic treatment.
Urigüen L; García-Fuster MJ; Callado LF; Morentin B; La Harpe R; Casadó V; Lluis C; Franco R; García-Sevilla JA; Meana JJ
Psychopharmacology (Berl); 2009 Oct; 206(2):313-24. PubMed ID: 19652957
[TBL] [Abstract][Full Text] [Related]
6. Maternal cannabis use alters ventral striatal dopamine D2 gene regulation in the offspring.
DiNieri JA; Wang X; Szutorisz H; Spano SM; Kaur J; Casaccia P; Dow-Edwards D; Hurd YL
Biol Psychiatry; 2011 Oct; 70(8):763-769. PubMed ID: 21820648
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoid receptor CNR1 expression and DNA methylation in human prefrontal cortex, hippocampus and caudate in brain development and schizophrenia.
Tao R; Li C; Jaffe AE; Shin JH; Deep-Soboslay A; Yamin R; Weinberger DR; Hyde TM; Kleinman JE
Transl Psychiatry; 2020 May; 10(1):158. PubMed ID: 32433545
[TBL] [Abstract][Full Text] [Related]
8. A preliminary study of endocannabinoid system regulation in psychosis: Distinct alterations of CNR1 promoter DNA methylation in patients with schizophrenia.
D'Addario C; Micale V; Di Bartolomeo M; Stark T; Pucci M; Sulcova A; Palazzo M; Babinska Z; Cremaschi L; Drago F; Carlo Altamura A; Maccarrone M; Dell'Osso B
Schizophr Res; 2017 Oct; 188():132-140. PubMed ID: 28108228
[TBL] [Abstract][Full Text] [Related]
9. Perinatal exposure to delta 9-tetrahydrocannabinol increases presynaptic dopamine D2 receptor sensitivity: a behavioral study in rats.
Moreno M; Trigo JM; Escuredo L; Rodríguez de Fonseca F; Navarro M
Pharmacol Biochem Behav; 2003 Jun; 75(3):565-75. PubMed ID: 12895674
[TBL] [Abstract][Full Text] [Related]
10. Effect on the expression of
Genis-Mendoza AD; Tovilla-Zárate CA; López-Narvaez L; Mendoza-Lorenzo P; Ostrosky-Wegman P; Nicolini H; González-Castro TB; Hernández-Diaz Y
Hereditas; 2016; 153():13. PubMed ID: 28096775
[TBL] [Abstract][Full Text] [Related]
11. Early Blockade of CB1 Receptors Ameliorates Schizophrenia-like Alterations in the Neurodevelopmental MAM Model of Schizophrenia.
Stark T; Iannotti FA; Di Martino S; Di Bartolomeo M; Ruda-Kucerova J; Piscitelli F; Wotjak CT; D'Addario C; Drago F; Di Marzo V; Micale V
Biomolecules; 2022 Jan; 12(1):. PubMed ID: 35053256
[TBL] [Abstract][Full Text] [Related]
12. Maternal immune activation leads to atypical turning asymmetry and reduced DRD2 mRNA expression in a rat model of schizophrenia.
Mundorf A; Kubitza N; Hünten K; Matsui H; Juckel G; Ocklenburg S; Freund N
Behav Brain Res; 2021 Sep; 414():113504. PubMed ID: 34331971
[TBL] [Abstract][Full Text] [Related]
13. Effects of chronic exposure to delta9-tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions.
Romero J; Garcia-Palomero E; Castro JG; Garcia-Gil L; Ramos JA; Fernandez-Ruiz JJ
Brain Res Mol Brain Res; 1997 Jun; 46(1-2):100-8. PubMed ID: 9191083
[TBL] [Abstract][Full Text] [Related]
14. Childhood obesity and the role of dopamine D2 receptor and cannabinoid receptor-1 gene polymorphisms.
Col Araz N; Nacak M; Oguzkan Balci S; Benlier N; Araz M; Pehlivan S; Balat A; Aynacioglu AS
Genet Test Mol Biomarkers; 2012 Dec; 16(12):1408-12. PubMed ID: 23057570
[TBL] [Abstract][Full Text] [Related]
15. Delta-9-tetrahydrocannabinol differentially suppresses emesis versus enhanced locomotor activity produced by chemically diverse dopamine D2/D3 receptor agonists in the least shrew (Cryptotis parva).
Darmani NA; Crim JL
Pharmacol Biochem Behav; 2005 Jan; 80(1):35-44. PubMed ID: 15652378
[TBL] [Abstract][Full Text] [Related]
16. Dopaminergic augmentation of delta-9-tetrahydrocannabinol (THC) discrimination: possible involvement of D(2)-induced formation of anandamide.
Solinas M; Tanda G; Wertheim CE; Goldberg SR
Psychopharmacology (Berl); 2010 Apr; 209(2):191-202. PubMed ID: 20179908
[TBL] [Abstract][Full Text] [Related]
17. Expression and function of CB1 receptor in the rat striatum: localization and effects on D1 and D2 dopamine receptor-mediated motor behaviors.
Martín AB; Fernandez-Espejo E; Ferrer B; Gorriti MA; Bilbao A; Navarro M; Rodriguez de Fonseca F; Moratalla R
Neuropsychopharmacology; 2008 Jun; 33(7):1667-79. PubMed ID: 17957223
[TBL] [Abstract][Full Text] [Related]
18. Effects of long-term exposure to delta9-THC on expression of cannabinoid receptor (CB1) mRNA in different rat brain regions.
Zhuang S; Kittler J; Grigorenko EV; Kirby MT; Sim LJ; Hampson RE; Childers SR; Deadwyler SA
Brain Res Mol Brain Res; 1998 Nov; 62(2):141-9. PubMed ID: 9813289
[TBL] [Abstract][Full Text] [Related]
19. Different effects of chronic THC on the neuroadaptive response of dopamine D2/3 receptor-mediated signaling in roman high- and roman low-avoidance rats.
Tournier BB; Dimiziani A; Tsartsalis S; Millet P; Ginovart N
Synapse; 2018 Apr; 72(4):. PubMed ID: 29265497
[TBL] [Abstract][Full Text] [Related]
20. Effects of perinatal exposure to delta 9-tetrahydrocannabinol on the fetal and early postnatal development of tyrosine hydroxylase-containing neurons in rat brain.
Bonnin A; de Miguel R; Castro JG; Ramos JA; Fernandez-Ruiz JJ
J Mol Neurosci; 1996; 7(4):291-308. PubMed ID: 8968950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
